Literature DB >> 16905583

Resolution of sclerodermatous myocarditis after autologous stem cell transplantation.

M Al-mashaleh, H Bak, J Moore, N Manolios, H Englert.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16905583      PMCID： PMC1798272          DOI： 10.1136/ard.2005.048405

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN： 0003-4967            Impact factor:   19.103


× No keyword cloud information.
  10 in total

1.  Pericardial involvement in systemic sclerosis.

Authors:  R J Byers; D A Marshall; A J Freemont
Journal:  Ann Rheum Dis       Date:  1997-06       Impact factor: 19.103

2.  Autologous stem cell transplantation in the treatment of systemic sclerosis: report from the EBMT/EULAR Registry.

Authors:  D Farge; J Passweg; J M van Laar; Z Marjanovic; C Besenthal; J Finke; H H Peter; F C Breedveld; W E Fibbe; C Black; C Denton; I Koetter; F Locatelli; A Martini; A V N Schattenberg; F van den Hoogen; L van de Putte; F Lanza; R Arnold; P A Bacon; S Bingham; F Ciceri; B Didier; J L Diez-Martin; P Emery; W Feremans; B Hertenstein; F Hiepe; R Luosujärvi; A Leon Lara; A Marmont; A M Martinez; H Pascual Cascon; C Bocelli-Tyndall; E Gluckman; A Gratwohl; A Tyndall
Journal:  Ann Rheum Dis       Date:  2004-08       Impact factor: 19.103

3.  [Autologous peripheral stem cell transplantation in a patient with diffuse systemic sclerosis: our experience].

Authors:  F Giorgetti; M L Minnucci; P Santori; L Ercoli; M Rossi; M Del Papa; G Morico; P Squadroni; A Olivieri; R Centurioni
Journal:  Reumatismo       Date:  2004 Jan-Mar

4.  Acute lupus myocarditis: clinical features and outcome of an oriental case series.

Authors:  W G Law; B Y Thong; T Y Lian; K O Kong; H H Chng
Journal:  Lupus       Date:  2005       Impact factor: 2.911

5.  Cardiac death after autologous stem cell transplantation (ASCT) for treatment of systemic sclerosis (SSc): no evidence for cyclophosphamide-induced cardiomyopathy.

Authors:  O Rosen; G Massenkeil; F Hiepe; S Pest; S Hauptmann; H Radtke; G Burmester; A Thiel; A Radbruch; B Heymer; R Arnold
Journal:  Bone Marrow Transplant       Date:  2001-03       Impact factor: 5.483

6.  [Cardiopulmonary function before and after cyclophosphamide treatment in severe systemic sclerosis: comparison of monthly intravenous bolus and autologous haematopoietic stem cell transplantation].

Authors:  C Toledano; C Henegar; D Ilie; D Launay; K Tiev; I Marie; Z Marjanovic; J Emmerich; J Cabane; S Ménasché; D Farge
Journal:  Rev Med Interne       Date:  2005-03-17       Impact factor: 0.728

7.  The possible role of myocardial biopsy in systemic sclerosis.

Authors:  O Liangos; L Neure; U Kühl; M Pauschinger; J Sieper; A Distler; P L Schwimmbeck; J Braun
Journal:  Rheumatology (Oxford)       Date:  2000-06       Impact factor: 7.580

8.  Severe organ involvement in systemic sclerosis with diffuse scleroderma.

Authors:  V D Steen; T A Medsger
Journal:  Arthritis Rheum       Date:  2000-11

9.  Consensus statement concerning cardiotoxicity occurring during haematopoietic stem cell transplantation in the treatment of autoimmune diseases, with special reference to systemic sclerosis and multiple sclerosis.

Authors:  R Saccardi; A Tyndall; G Coghlan; C Denton; G Edan; M Emdin; D Farge; A Fassas; J Finke; D Furst; M Lassus; G Mancardi; I Miniati; E Mini; F Pagliai; J Passweg; A Pignone; J M van Laar; C Bocelli-Tyndall; M Matucci-Cerinic
Journal:  Bone Marrow Transplant       Date:  2004-11       Impact factor: 5.483

Review 10.  High-dose immunosuppressive therapy and autologous progenitor cell transplantation for systemic sclerosis.

Authors:  Jacob M van Laar; Peter A McSweeney
Journal:  Best Pract Res Clin Haematol       Date:  2004-06       Impact factor: 3.020
  10 in total
  3 in total

Review 1.  Pharmacotherapy of systemic sclerosis.

Authors:  Arnold E Postlethwaite; L Jeff Harris; Syed H Raza; Swapna Kodura; Titilola Akhigbe
Journal:  Expert Opin Pharmacother       Date:  2010-04       Impact factor: 3.889

Review 2.  Update on assessment and management of primary cardiac involvement in systemic sclerosis.

Authors:  Vasiliki-Kalliopi Bournia; Christos Tountas; Athanase D Protogerou; Stylianos Panopoulos; Sophie Mavrogeni; Petros P Sfikakis
Journal:  J Scleroderma Relat Disord       Date:  2018-04-04

Review 3.  Primary heart involvement in systemic sclerosis, from conventional to innovative targeted therapeutic strategies.

Authors:  Arianna Ferlito; Corrado Campochiaro; Alessandro Tomelleri; Lorenzo Dagna; Giacomo De Luca
Journal:  J Scleroderma Relat Disord       Date:  2022-03-24
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.